The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
5 01 ACQUISITION CORP | COM CL A | 33836P105 | 1,994 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AC IMMUNE SA | SHS | H00263105 | 21,000 | 2,648,163 | SH | SOLE | 2,648,163 | 0 | 0 | ||
AKOUOS INC | COM | 00973J101 | 24,799 | 1,975,984 | SH | SOLE | 1,975,984 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 88,374 | 4,242,634 | SH | SOLE | 4,242,634 | 0 | 0 | ||
ALLOVIR INC | COM | 019818103 | 8,824 | 447,012 | SH | SOLE | 447,012 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 4,704 | 522,635 | SH | SOLE | 522,635 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 195,020 | 7,521,024 | SH | SOLE | 7,521,024 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 91,586 | 3,335,247 | SH | SOLE | 3,335,247 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 24,773 | 321,724 | SH | SOLE | 321,724 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,608 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 20,675 | 2,426,685 | SH | SOLE | 2,426,685 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 51,989 | 2,103,950 | SH | SOLE | 2,103,950 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 2,106 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 9,104 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 2,119 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 2,319 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 7,568 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 1,290 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 16,758 | 754,545 | SH | SOLE | 754,545 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 13,155 | 931,650 | SH | SOLE | 931,650 | 0 | 0 | ||
CONSONANCE HFW ACQUISITION C | *W EXP 10/28/202 | G2445M111 | 662 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
CONSONANCE HFW ACQUISITION C | SHS CL A | G2445M103 | 1,987 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CORVUS PHARMACEUTICALS INC | COM | 221015100 | 9,557 | 3,579,377 | SH | SOLE | 3,579,377 | 0 | 0 | ||
CYCLERION THERAPEUTICS INC | COM | 23255M105 | 6,264 | 1,606,276 | SH | SOLE | 1,606,276 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 25,062 | 1,260,019 | SH | SOLE | 1,260,019 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 4,524 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 26,112 | 1,224,175 | SH | SOLE | 1,224,175 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 656 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 1,969 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
FORMA THERAPEUTICS HLDGS INC | SHS | 34633R104 | 2,629 | 105,638 | SH | SOLE | 105,638 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | *W EXP 11/30/202 | G3710A113 | 651 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | CL A SHS | G3710A105 | 1,957 | 200,495 | SH | SOLE | 200,495 | 0 | 0 | ||
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 1,497 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
F-STAR THERAPEUTICS INC | COM | 30315R107 | 395 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 31,236 | 3,421,287 | SH | SOLE | 3,421,287 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 4,080 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 2,070 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
IGM BIOSCIENCES INC | COM | 449585108 | 3,164 | 38,030 | SH | SOLE | 38,030 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 26,570 | 1,035,864 | SH | SOLE | 1,035,864 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 35,229 | 1,411,975 | SH | SOLE | 1,411,975 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 4,970 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 582 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 9,277 | 387,357 | SH | SOLE | 387,357 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 77,655 | 3,724,437 | SH | SOLE | 3,724,437 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 25,192 | 519,416 | SH | SOLE | 519,416 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 3,588 | 366,867 | SH | SOLE | 366,867 | 0 | 0 | ||
MEIRAGTX HLDGS PLC | COM | G59665102 | 1,470 | 94,819 | SH | SOLE | 94,819 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 74,998 | 464,298 | SH | SOLE | 464,298 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 226,780 | 3,951,566 | SH | SOLE | 3,951,566 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 21,772 | 2,358,804 | SH | SOLE | 2,358,804 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 2,831 | 143,567 | SH | SOLE | 143,567 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 52,210 | 1,967,950 | SH | SOLE | 1,967,950 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 8,969 | 963,333 | SH | SOLE | 963,333 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 127,654 | 13,711,517 | SH | SOLE | 13,711,517 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 2,901 | 831,200 | SH | SOLE | 831,200 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 498 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 54,701 | 3,092,218 | SH | SOLE | 3,092,218 | 0 | 0 | ||
OVID THERAPEUTICS INC | COM | 690469101 | 23,781 | 6,082,200 | SH | SOLE | 6,082,200 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 1,708 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 580,125 | 11,284,280 | SH | SOLE | 11,284,280 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 164,208 | 4,487,776 | SH | SOLE | 4,487,776 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 1,559 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 96,201 | 3,318,410 | SH | SOLE | 3,318,410 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 80,871 | 2,618,036 | SH | SOLE | 2,618,036 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 33,682 | 9,202,702 | SH | SOLE | 9,202,702 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 5,450 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
TRANSLATE BIO INC | COM | 89374L104 | 28,889 | 1,048,976 | SH | SOLE | 1,048,976 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 330 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 989 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 6,025 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 169,212 | 4,906,106 | SH | SOLE | 4,906,106 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 10,640 | 200,000 | SH | SOLE | 200,000 | 0 | 0 |